Global Noninvasive Cancer Biomarkers Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 6215

Noninvasive cancer biomarkers are the alternatives for the invasive tissue biopsies used for the detection of tumor presence in various cancer types. These biomarkers are used for detecting the state of disease. There are various types of biomarkers available such as circulation tumor DNA, serum micro RNAs, DNA methylation based biomarker, and protein based biomarkers and others.
Increased cancer occurrence rate and development in the diagnosis and treatment is creating the market for noninvasive cancer biomarkers. Moreover, increased funding by various government as well as non-government organization in the oncology segment also supports the overall market. Availability of large number of kits in the market and the marketing strategies used by various manufacturers is creating competitive environment for the noninvasive cancer biomarkers market. Continuous research in this field also deepens the molecular understanding of cancer which increases the availability of biomarkers in the market.
With large number of research and diagnostic laboratories as well as healthcare facilities, North America holds the largest market for the usage of these noninvasive cancer biomarkers for disease diagnosis and prognosis. This is followed by Europe with increasing academic as well as bio-pharmaceutical research activities and the advancement in healthcare facilities. Asia-Pacific is expected to be the growing market for the noninvasive cancer biomarkers because of increasing prevalence of different types of cancers and along with this, government support in the availability of healthcare facilities also supports the growth over the region.

The global Noninvasive Cancer Biomarkers market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Noninvasive Cancer Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Noninvasive Cancer Biomarkers market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Abbott
Bio-Rad
Merck
Roche
Sino Biological
Thermo Fisher Scientific
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Protein Based Biomarkers
DNA Based Biomarkers
MRNA Based Biomarkers
Micro RNA Based Biomarkers

Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes

Table of Contents

Executive Summary
1 Noninvasive Cancer Biomarkers Market Overview
1.1 Product Overview and Scope of Noninvasive Cancer Biomarkers
1.2 Noninvasive Cancer Biomarkers Segment by Type
1.2.1 Global Noninvasive Cancer Biomarkers Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Protein Based Biomarkers
1.2.3 DNA Based Biomarkers
1.2.4 MRNA Based Biomarkers
1.2.5 Micro RNA Based Biomarkers
1.3 Noninvasive Cancer Biomarkers Segment by Application
1.3.1 Noninvasive Cancer Biomarkers Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.4 Global Noninvasive Cancer Biomarkers Market by Region
1.4.1 Global Noninvasive Cancer Biomarkers Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Noninvasive Cancer Biomarkers Market Size
1.5.1 Global Noninvasive Cancer Biomarkers Revenue (2014-2025)
1.5.2 Global Noninvasive Cancer Biomarkers Production (2014-2025)

2 Global Noninvasive Cancer Biomarkers Market Competition by Manufacturers
2.1 Global Noninvasive Cancer Biomarkers Production Market Share by Manufacturers (2014-2019)
2.2 Global Noninvasive Cancer Biomarkers Revenue Share by Manufacturers (2014-2019)
2.3 Global Noninvasive Cancer Biomarkers Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Noninvasive Cancer Biomarkers Production Sites, Area Served, Product Types
2.5 Noninvasive Cancer Biomarkers Market Competitive Situation and Trends
2.5.1 Noninvasive Cancer Biomarkers Market Concentration Rate
2.5.2 Noninvasive Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Noninvasive Cancer Biomarkers Production Market Share by Regions
3.1 Global Noninvasive Cancer Biomarkers Production Market Share by Regions
3.2 Global Noninvasive Cancer Biomarkers Revenue Market Share by Regions (2014-2019)
3.3 Global Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Noninvasive Cancer Biomarkers Production
3.4.1 North America Noninvasive Cancer Biomarkers Production Growth Rate (2014-2019)
3.4.2 North America Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Noninvasive Cancer Biomarkers Production
3.5.1 Europe Noninvasive Cancer Biomarkers Production Growth Rate (2014-2019)
3.5.2 Europe Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Noninvasive Cancer Biomarkers Production (2014-2019)
3.6.1 China Noninvasive Cancer Biomarkers Production Growth Rate (2014-2019)
3.6.2 China Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Noninvasive Cancer Biomarkers Production (2014-2019)
3.7.1 Japan Noninvasive Cancer Biomarkers Production Growth Rate (2014-2019)
3.7.2 Japan Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Noninvasive Cancer Biomarkers Consumption by Regions
4.1 Global Noninvasive Cancer Biomarkers Consumption by Regions
4.2 North America Noninvasive Cancer Biomarkers Consumption (2014-2019)
4.3 Europe Noninvasive Cancer Biomarkers Consumption (2014-2019)
4.4 China Noninvasive Cancer Biomarkers Consumption (2014-2019)
4.5 Japan Noninvasive Cancer Biomarkers Consumption (2014-2019)

5 Global Noninvasive Cancer Biomarkers Production, Revenue, Price Trend by Type
5.1 Global Noninvasive Cancer Biomarkers Production Market Share by Type (2014-2019)
5.2 Global Noninvasive Cancer Biomarkers Revenue Market Share by Type (2014-2019)
5.3 Global Noninvasive Cancer Biomarkers Price by Type (2014-2019)
5.4 Global Noninvasive Cancer Biomarkers Production Growth by Type (2014-2019)

6 Global Noninvasive Cancer Biomarkers Market Analysis by Applications
6.1 Global Noninvasive Cancer Biomarkers Consumption Market Share by Application (2014-2019)
6.2 Global Noninvasive Cancer Biomarkers Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Noninvasive Cancer Biomarkers Business
7.1 Abbott
7.1.1 Abbott Noninvasive Cancer Biomarkers Production Sites and Area Served
7.1.2 Noninvasive Cancer Biomarkers Product Introduction, Application and Specification
7.1.3 Abbott Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Bio-Rad
7.2.1 Bio-Rad Noninvasive Cancer Biomarkers Production Sites and Area Served
7.2.2 Noninvasive Cancer Biomarkers Product Introduction, Application and Specification
7.2.3 Bio-Rad Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Merck
7.3.1 Merck Noninvasive Cancer Biomarkers Production Sites and Area Served
7.3.2 Noninvasive Cancer Biomarkers Product Introduction, Application and Specification
7.3.3 Merck Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Roche
7.4.1 Roche Noninvasive Cancer Biomarkers Production Sites and Area Served
7.4.2 Noninvasive Cancer Biomarkers Product Introduction, Application and Specification
7.4.3 Roche Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Sino Biological
7.5.1 Sino Biological Noninvasive Cancer Biomarkers Production Sites and Area Served
7.5.2 Noninvasive Cancer Biomarkers Product Introduction, Application and Specification
7.5.3 Sino Biological Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Noninvasive Cancer Biomarkers Production Sites and Area Served
7.6.2 Noninvasive Cancer Biomarkers Product Introduction, Application and Specification
7.6.3 Thermo Fisher Scientific Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served

8 Noninvasive Cancer Biomarkers Manufacturing Cost Analysis
8.1 Noninvasive Cancer Biomarkers Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Noninvasive Cancer Biomarkers
8.4 Noninvasive Cancer Biomarkers Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Noninvasive Cancer Biomarkers Distributors List
9.3 Noninvasive Cancer Biomarkers Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Noninvasive Cancer Biomarkers Market Forecast
11.1 Global Noninvasive Cancer Biomarkers Production, Revenue Forecast
11.1.1 Global Noninvasive Cancer Biomarkers Production Growth Rate Forecast (2019-2025)
11.1.2 Global Noninvasive Cancer Biomarkers Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Noninvasive Cancer Biomarkers Price and Trend Forecast (2019-2025)
11.2 Global Noninvasive Cancer Biomarkers Production Forecast by Regions (2019-2025)
11.2.1 North America Noninvasive Cancer Biomarkers Production, Revenue Forecast (2019-2025)
11.2.2 Europe Noninvasive Cancer Biomarkers Production, Revenue Forecast (2019-2025)
11.2.3 China Noninvasive Cancer Biomarkers Production, Revenue Forecast (2019-2025)
11.2.4 Japan Noninvasive Cancer Biomarkers Production, Revenue Forecast (2019-2025)
11.3 Global Noninvasive Cancer Biomarkers Consumption Forecast by Regions (2019-2025)
11.3.1 North America Noninvasive Cancer Biomarkers Consumption Forecast (2019-2025)
11.3.2 Europe Noninvasive Cancer Biomarkers Consumption Forecast (2019-2025)
11.3.3 China Noninvasive Cancer Biomarkers Consumption Forecast (2019-2025)
11.3.4 Japan Noninvasive Cancer Biomarkers Consumption Forecast (2019-2025)
11.4 Global Noninvasive Cancer Biomarkers Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Noninvasive Cancer Biomarkers Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer